{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T21:50:46Z","timestamp":1792705846839,"version":"4.5.0"},"reference-count":29,"publisher":"Wiley","issue":"8","license":[{"start":{"date-parts":[[2014,5,6]],"date-time":"2014-05-06T00:00:00Z","timestamp":1399334400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Journal of Clinical Pharma"],"published-print":{"date-parts":[[2014,8]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:label\/><jats:p>Evidence for the association between hypomagnesemia and proton pump inhibitors (PPIs), highlighted by the 2011 FDA Drug Safety Communication, rests mainly on studies in hospitalized patients. Our objectives were to determine the prevalence of hypomagnesemia and its association with PPIs in the community setting. We performed a retrospective cross\u2010sectional analysis of a large health maintenance organization administrative database, including ambulatory patients with \u22651 serum magnesium concentrations between 2008 and 2011, the lowest referred to as \u201cindex magnesium.\u201d In cases with any (index magnesium \u22640.7\u2009mmol\/L) or severe (\u22640.55\u2009mmol\/L) hypomagnesemia, we analyzed (vs. controls, &gt;0.7\u2009mmol\/L) the association with PPI or H<jats:sub>2<\/jats:sub>\u2010blocker use during the 4\u201312 months preceding the index magnesium by logistic regression analysis, adjusting for confounders. Among 95,205 subjects, 5,696 (6.0%) had any hypomagnesemia, which was severe in 454 (0.5%), with twofold higher prevalences in those with established risk factors. PPI use during the 4 months preceding the index magnesium was more common in cases of any hypomagnesemia (adjusted OR\u2009=\u20091.66; 95% CI, 1.55\u20131.78) and severe hypomagnesemia (adjusted OR\u2009=\u20093.79; 2.99\u20134.82) than in controls without acid suppression. Hypomagnesemia remained significantly associated with PPI use when using H<jats:sub>2<\/jats:sub>\u2010blocker\u2010users as reference (adjusted OR\u2009=\u20091.25 [<jats:italic>P<\/jats:italic>\u2009=\u20090.003] and 2.65 [<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001] for any and severe hypomagnesemia, respectively). We conclude that hypomagnesemia is associated with PPI use in ambulatory patients.<\/jats:p><\/jats:sec>","DOI":"10.1002\/jcph.316","type":"journal-article","created":{"date-parts":[[2014,4,28]],"date-time":"2014-04-28T04:32:43Z","timestamp":1398659563000},"page":"889-895","source":"Crossref","is-referenced-by-count":58,"title":["The association of proton pump inhibitors and hypomagnesemia in the community setting"],"prefix":"10.1002","volume":"54","author":[{"given":"Noa","family":"Markovits","sequence":"first","affiliation":[{"name":"Department of Pharmacy and Clinical Pharmacology Maccabi Healthcare Services Tel Aviv Israel"},{"name":"Institute of Clinical Pharmacology Sheba Medical Center Tel Hashomer Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronen","family":"Loebstein","sequence":"additional","affiliation":[{"name":"Department of Pharmacy and Clinical Pharmacology Maccabi Healthcare Services Tel Aviv Israel"},{"name":"Institute of Clinical Pharmacology Sheba Medical Center Tel Hashomer Israel"},{"name":"Sackler School of Medicine Tel Aviv University Tel Aviv Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hillel","family":"Halkin","sequence":"additional","affiliation":[{"name":"Department of Pharmacy and Clinical Pharmacology Maccabi Healthcare Services Tel Aviv Israel"},{"name":"Institute of Clinical Pharmacology Sheba Medical Center Tel Hashomer Israel"},{"name":"Sackler School of Medicine Tel Aviv University Tel Aviv Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Bialik","sequence":"additional","affiliation":[{"name":"Department of Pharmacy and Clinical Pharmacology Maccabi Healthcare Services Tel Aviv Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janet","family":"Landes\u2010Westerman","sequence":"additional","affiliation":[{"name":"Department of Pharmacy and Clinical Pharmacology Maccabi Healthcare Services Tel Aviv Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Lomnicky","sequence":"additional","affiliation":[{"name":"Department of Pharmacy and Clinical Pharmacology Maccabi Healthcare Services Tel Aviv Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Kurnik","sequence":"additional","affiliation":[{"name":"Department of Pharmacy and Clinical Pharmacology Maccabi Healthcare Services Tel Aviv Israel"},{"name":"Division of Clinical Pharmacology and Toxicology Rambam Health Care Campus Haifa Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2014,5,6]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc066308"},{"key":"e_1_2_6_3_1","doi-asserted-by":"publisher","DOI":"10.2165\/00002018-200528090-00003"},{"key":"e_1_2_6_4_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.39505.738981.BE"},{"key":"e_1_2_6_5_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2008.03194.x"},{"key":"e_1_2_6_6_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2009.11.019"},{"key":"e_1_2_6_7_1","doi-asserted-by":"publisher","DOI":"10.1093\/qjmed\/hcq021"},{"key":"e_1_2_6_8_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-010-1560-3"},{"key":"e_1_2_6_9_1","doi-asserted-by":"publisher","DOI":"10.1097\/MOG.0b013e32833ff5d6"},{"key":"e_1_2_6_10_1","unstructured":"FDA Drug Safety Communication. Low magnesium levels can be associated with long\u2010term use of proton pump inhibitor drugs (PPIs) Available at:http:\/\/www.fda.gov\/Drugs\/Drug\/ucm245011.htm. Last Accessed on November 14 2013."},{"key":"e_1_2_6_11_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-155-6-201109200-00022"},{"key":"e_1_2_6_12_1","doi-asserted-by":"publisher","DOI":"10.1002\/pds.3224"},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2012.452"},{"key":"e_1_2_6_14_1","doi-asserted-by":"publisher","DOI":"10.7150\/ijms.4397"},{"key":"e_1_2_6_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ramb.2012.12.007"},{"key":"e_1_2_6_16_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2013.02.373"},{"key":"e_1_2_6_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0009-9236(03)00166-8"},{"key":"e_1_2_6_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.healthpol.2009.12.007"},{"key":"e_1_2_6_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2012.08.013"},{"key":"e_1_2_6_20_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2011.04321.x"},{"key":"e_1_2_6_21_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2012.07.033"},{"key":"e_1_2_6_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0895-4356(96)00268-5"},{"key":"e_1_2_6_23_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-150-9-200905050-00006"},{"key":"e_1_2_6_24_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.111.082511"},{"key":"e_1_2_6_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2010.08.073"},{"key":"e_1_2_6_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2012.06.037"},{"key":"e_1_2_6_27_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1001045"},{"key":"e_1_2_6_28_1","doi-asserted-by":"publisher","DOI":"10.1001\/archinternmed.2011.199"},{"key":"e_1_2_6_29_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2012.05201.x"},{"key":"e_1_2_6_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2010.06.036"}],"container-title":["The Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fjcph.316","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/accp1.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/jcph.316","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,3]],"date-time":"2023-10-03T14:20:57Z","timestamp":1696342857000},"score":1,"resource":{"primary":{"URL":"https:\/\/accp1.onlinelibrary.wiley.com\/doi\/10.1002\/jcph.316"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5,6]]},"references-count":29,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2014,8]]}},"alternative-id":["10.1002\/jcph.316"],"URL":"https:\/\/doi.org\/10.1002\/jcph.316","archive":["Portico"],"relation":{},"ISSN":["0091-2700","1552-4604"],"issn-type":[{"value":"0091-2700","type":"print"},{"value":"1552-4604","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,5,6]]}}}